IL-17a Promotes Hepatocellular Carcinoma by Increasing FAP Expression in Hepatic Stellate Cells via Activation of the STAT3 Signaling Pathway

0
35
In vivo and in vitro experiments were performed to verify the promoting effects of IL-17a administration, IL-17a overexpression, and FAP upregulation in HSCs on liver fibrosis and liver tumorigenesis.
[Cell Death Discovery]
Full Article